Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.77	26.14	9.7	0.46	16.58	-
Cash & Short-Term Investments	19.77	26.14	9.7	0.46	16.58	-
Cash Growth	-59.60%	169.48%	2032.09%	-97.26%	-	-
Prepaid Expenses	6.21	3.87	3.37	2.03	1.71	-
Other Current Assets	1.37	0.94	0.33	0.16	0.13	0.2
Total Current Assets	27.35	30.95	13.4	2.64	18.41	0.2
Property, Plant & Equipment	0.6	0.72	0.79	0.17	0.33	-
Total Assets	27.95	31.67	14.19	2.82	18.74	0.2
Accounts Payable	1.4	1.06	0.84	0.89	0.74	0.18
Accrued Expenses	4.14	3.56	3.23	2.24	1.21	0.18
Short-Term Debt	-	-	-	-	-	2.51
Current Portion of Leases	0.55	0.56	0.33	0.16	0.15	-
Other Current Liabilities	10.59	18.94	13.13	-	-	-
Total Current Liabilities	16.68	24.12	17.53	3.28	2.11	2.88
Long-Term Leases	-	0.12	0.47	-	0.16	-
Total Liabilities	16.68	24.24	18	3.28	2.26	2.88
Common Stock	0.12	0.11	0.04	0.02	0.02	0.01
Additional Paid-In Capital	111.85	108.59	60.7	33.52	32.41	3.24
Retained Earnings	-100.7	-101.27	-64.54	-34	-15.94	-5.92
Shareholders' Equity	11.27	7.43	-3.81	-0.47	16.48	-2.67
Total Liabilities & Equity	27.95	31.67	14.19	2.82	18.74	0.2
Total Debt	0.55	0.68	0.79	0.16	0.31	2.51
Net Cash (Debt)	19.22	25.46	8.91	0.3	16.27	-2.51
Net Cash Growth	-60.14%	185.82%	2869.33%	-98.16%	-	-
Net Cash Per Share	2.20	3.80	3.63	0.20	13.94	-2.96
Filing Date Shares Outstanding	12.06	11.97	3.48	1.52	1.5	0.89
Total Common Shares Outstanding	11.97	11.38	3.48	1.52	1.5	0.85
Working Capital	10.67	6.83	-4.14	-0.64	16.31	-2.67
Book Value Per Share	0.94	0.65	-1.10	-0.31	10.99	-3.14
Tangible Book Value	11.27	7.43	-3.81	-0.47	16.48	-2.67
Tangible Book Value Per Share	0.94	0.65	-1.10	-0.31	10.99	-3.14
Machinery	0.08	0.06	0.02	0.01	0.01	-
Construction In Progress	-	0.01	-	-	-	-
Leasehold Improvements	0.05	0.05	0.02	0.02	0.02	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q